UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010923 |
|---|---|
| Receipt number | R000012783 |
| Scientific Title | A clinical phase II study assessing the safety and efficacy of readministration of bendamustine monotherapy or bendamustine/rituximab for relapsed low grade B cell non-Hodgkin lymphoma or mantle cell lymphoma patients previously treated with bendamustine containing chemothearpy |
| Date of disclosure of the study information | 2013/06/17 |
| Last modified on | 2020/12/15 12:38:23 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/06/10 21:02:50 | ||
| 2 | Update | 2013/12/03 22:06:10 | TEL Last name of contact person Last name of contact person TEL |
|
| 3 | Update | 2015/11/19 11:17:35 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
| 4 | Update | 2018/12/18 12:40:32 | UMIN ID1 |
|
| 5 | Update | 2018/12/18 15:15:40 | Recruitment status Last follow-up date |
|
| 6 | Update | 2020/12/15 12:38:23 | Recruitment status Date of IRB Date of closure to data entry Date trial data considered complete Date analysis concluded |
